Disclosures for "Effects of Ofatumumab Treatment on Immune Cells Landscape in Patients With Relapsing-remitting Multiple Sclerosis"
-
Dr. Yang has nothing to disclose.
-
Tianxiang Zhang has nothing to disclose.
-
Mrs. Feng has nothing to disclose.
-
The institution of Prof. Zhang has received research support from Novartis.